Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.
Laureys G, Willekens B, Vanopdenbosch L, Deryck O, Selleslag D, D'Haeseleer M, De Becker A, Dubois B, Dierickx D, Perrotta G, De Wilde V, van Pesch V, Straetmans N, Dive D, Beguin Y, Van Wijmeersch B, Theunissen K, Kerre T, Van de Velde A. Laureys G, et al. Among authors: perrotta g. Acta Neurol Belg. 2018 Jun;118(2):161-168. doi: 10.1007/s13760-018-0905-0. Epub 2018 Mar 13. Acta Neurol Belg. 2018. PMID: 29536270 Free article.
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.
Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, Nath A, Ohayon J, van Pesch V, Perrotta G, Pot C, Théaudin M, Martinelli V, Scotti R, Wu T, Du Pasquier R, Calabresi PA, Filippi M, Reich DS, Absinta M. Maggi P, et al. Among authors: perrotta g. Ann Neurol. 2020 Nov;88(5):1034-1042. doi: 10.1002/ana.25877. Epub 2020 Sep 9. Ann Neurol. 2020. PMID: 32799417 Free PMC article.
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Smirnakis K, Xiao S, Kong G, Kuhelj R, Campbell N; NOVA study investigators. Foley JF, et al. Lancet Neurol. 2022 Jul;21(7):608-619. doi: 10.1016/S1474-4422(22)00143-0. Epub 2022 Apr 25. Lancet Neurol. 2022. PMID: 35483387 Clinical Trial.
B cell depletion therapy does not resolve chronic active multiple sclerosis lesions.
Maggi P, Bulcke CV, Pedrini E, Bugli C, Sellimi A, Wynen M, Stölting A, Mullins WA, Kalaitzidis G, Lolli V, Perrotta G, El Sankari S, Duprez T, Li X, Calabresi PA, van Pesch V, Reich DS, Absinta M. Maggi P, et al. Among authors: perrotta g. EBioMedicine. 2023 Aug;94:104701. doi: 10.1016/j.ebiom.2023.104701. Epub 2023 Jul 10. EBioMedicine. 2023. PMID: 37437310 Free PMC article.
Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global Community.
Van Hijfte L, Cambron M, Capron B, Dachy B, Decoo D, Dive D, Dubois B, Sankari SE, London F, Perrotta G, Popescu V, Van Pesch V, Van Wijmeersch B, Willekens B, Laureys G; Belgian Study Group for Multiple Sclerosis (BSGMS). Van Hijfte L, et al. Among authors: perrotta g. Mult Scler Relat Disord. 2024 May;85:105540. doi: 10.1016/j.msard.2024.105540. Epub 2024 Mar 11. Mult Scler Relat Disord. 2024. PMID: 38489948
Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L. Maggi P, et al. Among authors: perrotta g. Ann Neurol. 2018 Feb;83(2):283-294. doi: 10.1002/ana.25146. Epub 2018 Feb 15. Ann Neurol. 2018. PMID: 29328521 Free PMC article.
120 results